Begin Main Content Area

​Pharmacy and Therapeutics (P&T) Committee

Related Links

The Department of Human Services (Department) appointed the P&T Committee to act in an advisory capacity to the Department and the Office of Medical Assistance Programs (OMAP) and provide an unbiased clinical perspective on the Department's Statewide Preferred Drug List (PDL). Recommendations from the committee must be reviewed and approved by the Secretary of the Department of Human Services.

Change Healthcare provides clinical and financial analysis support to the P&T Committee.

P&T Committee Meeting Information 

Upcoming Meetings



The list of drug classes for review will be posted prior to the meeting.

Past Pharmacy and Therapeutics Committee Meetings

Review the Pharmacy and Therapeutics Committee By-Laws

Committee Information

Composition and responsibilities of the committee:

    • Comprised of department medical directors, external physicians, pharmacists, consumer advocates, and specialists as needed for drug class reviews.
    • Recommend a clinically-based PDL with an emphasis on effectiveness, safety, and outcomes.
    • Recommend prior authorization guidelines for non-preferred drugs as well as certain preferred drugs using current community standards for prescribing.
    • Recommend Prospective and Retrospective Drug Utilization Review Program Review and Development.
Name Specialty  Independent*  Department**  MCO
Ivonne Acrich, MDAd Hoc Child/Adolescent Psychiatrist
​Dale Adair, MD, FAPA​Office of Mental Health & Substance Abuse Services Medical Director​X
Christopher Antypas, PharmDCommunity PharmacistX  
Lawrence Appel, MD, SFHMMedical Director, Office of Long Term Living
Cheston Berlin, Jr., MDPediatricianX
​Tony Byler, MD​PerformCare Psychiatrist​X

Terri Cathers, PharmD,
Chair (tie-breaker vote only)

OMAP Pharmacy Director
​Michael Colvin, PharmD
​AmeriHealth Caritas & Keystone First HealthChoices & Community HealthChoices Pharmacist

Sharon Connor, PharmDAcademic PharmacistX  
​Molly DiMatteo, DO
​Family Practitioner
​Oluwatoyin Fadeyibi, PharmD, MPH​Community Behavioral Health Pharmacist​X
Andrea Fox, MDInternistX  
Donald Gerhart, RPhCommunity PharmacistX  
James Hancovsky, RPh, MBAUnited Health Care Pharmacy Director  X
Rosemary Keffer, MDAd Hoc Adult Psychiatrist X 
​David Kelley, MD
​OMAP Chief Medical Officer, Office of Medical Assistance Programs​X
Peter Kreckel, RPhCommunity PharmacistX  
Renee Licwinko, RPhGateway Health Plan Pharmacist  X
Meghan McNelly, PharmDPA Health & Wellness Pharmacist  X
Michele Musheno, RPh, MSAcademic/Hospital PharmacistX  
​Geoffrey Neimark, MD​Community Care Behavioral Health Psychiatrist​X
Ian Paul, MD, Vice Chair
Adam Raphael Rom, MDFamily PractitionerX  
Amy Saracino, DO
Ad Hoc Adult Psychiatrist X
​Christopher Squillaro, DO
​Magellan Behavioral Health of PA Medical Director

Kevin Szczecina, RPhGeisinger Health Plan Pharmacist  X
​Mahmood Usman, MD​Beacon Health Options Psychiatrist​X
​Fallan Vaisberg, PharmD, RPh
​Health Partners Plans Formulary Pharmacist

Andreas Wali, MD
Verlyn Warrington, MD
Bariatric Medicine Specialist/Family Medicine Doctor
Lloyd Wertz
Consumer/Family AdvocateX  
​Lauren Zandier, PharmD​UPMC For You Pharmacist​X
VacantConsumer RepresentativeX  

 * - Independent Members are not employed by the Department
** - Department Members are employed by the Department on a full or part-time basis

Effective April 17, 2023 / Last modified September 13, 2023